Literature DB >> 10414468

The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis.

J Haux1, A C Johnsen, B Steinkjer, K Egeberg, A Sundan, T Espevik.   

Abstract

The Fas/Fas-ligand (FasL) system seems to play a key role in regulating immunoresponses. Highly purified CD56+CD3- natural killer (NK) cells were found to be resistant to the apoptosis-inducing Fas mAb CH11 in the absence or in the presence of interleukin-2 (IL-2) for up to 3 days. However, NK cells activated with IL-2 for 3 days became apoptotic following combined treatment with CH11 and actinomycin D, suggesting the presence of an intact apoptotic machinery. In contrast, NK cells cultivated in IL-2 for 6 days became sensitive to CH11-induced apoptosis without addition of actinomycin D. At this time, a pronounced up-regulation of the Fas protein on the NK cell membrane was detected. By using reverse transcription/polymerase chain reaction it was found that the anti-apoptotic gene FLIP was strongly expressed in NK cells for up to 6 days of IL-2 stimulation. After day 6, a time-dependent decrease in the expression of FLIP was observed concomitantly with increased sensitivity for Fas-mediated apoptosis. The amount of apoptotic and necrotic NK cells in the presence of IL-2 increased in a time-dependent manner, reaching 40% at day 6 of culture. The amount of apoptotic and necrotic NK cells was reduced in the presence of Fas-Fc protein. In addition, IL-2 stimulated the NK cells to release soluble FasL in a time-dependent manner, whereas membrane FasL did not seem to increase in a similar manner. These results indicate that Fas/FasL interactions are involved in the down-regulation of IL-2-activated human NK cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414468     DOI: 10.1007/s002620050558

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  4 in total

1.  IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo.

Authors:  Esther Cha; Laura Graham; Masoud H Manjili; Harry D Bear
Journal:  Breast Cancer Res Treat       Date:  2009-10-14       Impact factor: 4.872

2.  Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells.

Authors:  Johanna K Morales; Maciej Kmieciak; Laura Graham; Marta Feldmesser; Harry D Bear; Masoud H Manjili
Journal:  Cancer Immunol Immunother       Date:  2008-11-01       Impact factor: 6.968

3.  Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.

Authors:  Hanh K Le; Laura Graham; Catriona H T Miller; Maciej Kmieciak; Masoud H Manjili; Harry Douglas Bear
Journal:  Cancer Immunol Immunother       Date:  2009-02-06       Impact factor: 6.968

4.  Efficient recruitment of c-FLIPL to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma.

Authors:  Azuchi Masuda; Yasushi Isobe; Koichi Sugimoto; Mayumi Yoshimori; Ayako Arai; Norio Komatsu
Journal:  Cancer Sci       Date:  2020-01-31       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.